西藏药业
(600211)
| 流通市值：130.15亿 | | | 总市值：130.15亿 |
| 流通股本：3.22亿 | | | 总股本：3.22亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,176,030,498.94 | 1,554,436,303.07 | 723,548,218.03 | 2,981,538,230.43 |
| 营业总成本 | 1,545,783,223.78 | 1,092,056,208.13 | 502,684,914.58 | 1,988,734,371.46 |
| 其他经营收益 | | | | |
| 营业利润 | 804,907,843.73 | 636,374,380.95 | 316,296,922.74 | 1,043,831,968.47 |
| 利润总额 | 801,583,136.49 | 636,945,067.83 | 316,636,987.52 | 1,040,617,869.2 |
| 净利润 | 714,116,757.12 | 571,128,354.71 | 282,833,468.95 | 916,980,955.72 |
| 每股收益 | | | | |
| 其他综合收益 | -28,684,314.37 | -23,721,415.55 | -12,073,799.08 | -17,441,769.97 |
| 综合收益总额 | 685,432,442.75 | 547,406,939.16 | 270,759,669.87 | 899,539,185.75 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 4,746,642,512.14 | 4,895,649,487.39 | 4,795,724,455.11 | 4,637,316,550.09 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,510,827,552.67 | 1,543,865,823.42 | 1,596,088,521.79 | 1,630,070,617.82 |
| 资产总计 | 6,257,470,064.81 | 6,439,515,310.81 | 6,391,812,976.9 | 6,267,387,167.91 |
| 流动负债: | | | | |
| 流动负债合计 | 1,733,515,526.57 | 1,702,873,823 | 1,662,701,716.89 | 1,640,125,995.34 |
| 非流动负债: | | | | |
| 非流动负债合计 | 526,678,828.43 | 512,704,431.62 | 501,358,427.21 | 489,779,958.59 |
| 负债合计 | 2,260,194,355 | 2,215,578,254.62 | 2,164,060,144.1 | 2,129,905,953.93 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,705,367,991.36 | 3,913,459,051.22 | 3,899,996,548.04 | 3,798,429,273.3 |
| 股东权益合计 | 3,997,275,709.81 | 4,223,937,056.19 | 4,227,752,832.8 | 4,137,481,213.98 |
| 负债和股东权益合计 | 6,257,470,064.81 | 6,439,515,310.81 | 6,391,812,976.9 | 6,267,387,167.91 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,945,370,691.44 | 2,017,330,557.84 | 1,140,989,052.39 | 3,280,245,803.15 |
| 经营活动现金流出小计 | 2,139,095,319.3 | 1,538,173,455.25 | 757,538,069.72 | 2,275,494,997.23 |
| 经营活动产生的现金流量净额 | 806,275,372.14 | 479,157,102.59 | 383,450,982.67 | 1,004,750,805.92 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,913,827,387.69 | 2,829,438,905.11 | 1,326,273,251.13 | 4,554,882,655.3 |
| 投资活动现金流出小计 | 4,092,279,253.97 | 3,283,750,939.62 | 1,699,053,183.6 | 5,143,957,010.34 |
| 投资活动产生的现金流量净额 | -178,451,866.28 | -454,312,034.51 | -372,779,932.47 | -589,074,355.04 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,398,041,585.45 | 1,039,062,405.85 | 327,121,130.21 | 1,009,797,193.37 |
| 筹资活动现金流出小计 | 1,758,621,064.29 | 1,153,704,245.21 | 229,185,029.34 | 1,132,420,354.43 |
| 筹资活动产生的现金流量净额 | -360,579,478.84 | -114,641,839.36 | 97,936,100.87 | -122,623,161.06 |
| 汇率变动对现金及现金等价物的影响 | -56,698,855.3 | -16,251,799.71 | -21,090,592.86 | -22,454,136.39 |
| 现金及现金等价物净增加额 | 210,545,171.72 | -106,048,570.99 | 87,516,558.21 | 270,599,153.43 |
| 期末现金及现金等价物余额 | 1,787,045,491.2 | 1,470,451,748.49 | 1,664,016,877.69 | 1,576,500,319.48 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -106,048,570.99 | - | 270,599,153.43 |
最新报告期：2026-08-20| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 首创证券 | 王斌 | 3.09 | 2.91 | 3.10 | 2026-08-20 |
| 西南证券 | 杜向阳 | 3.23 | 3.44 | 3.58 | 2026-08-18 |